Abstract
Acute myeloid leukemia (AML) is a heterogeneous blood cancer. Effective immunotherapies for AML are hindered by a lack of understanding of the tumor m......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
